David Digiusto, Ph.D.
CTO and SVP Stem Cells and Regenerative Medicine
Professional Overview
David Digiusto, Ph.D., is an accomplished executive with extensive expertise in stem cell research, cell and gene therapies, and regenerative medicine. He currently serves as the CTO and SVP of Stem Cells and Regenerative Medicine at Resilience, as well as the SVP of Cell & Gene Therapies Preclinical & Clinical Manufacturing at Vertex Pharmaceuticals. Dr. Digiusto's industry experience and technical prowess have made him a recognized leader in the field of cellular therapeutics.
Experience Summary
Current Roles
CTO and SVP Stem Cells and Regenerative Medicine, Resilience
- Oversees the strategic direction and technical operations of the company's stem cell and regenerative medicine initiatives
- Leads a team of researchers and engineers in the development of innovative cell-based therapies
- Drives the advancement of cutting-edge technologies and manufacturing processes to support the company's pipeline
SVP, Cell & Gene Therapies Preclinical & Clinical Mfg - CMC, Vertex Pharmaceuticals
- Responsible for the oversight and management of Vertex's cell and gene therapy manufacturing operations
- Collaborates with cross-functional teams to ensure seamless and efficient clinical-stage manufacturing
- Implements robust quality control and process optimization strategies to support the advancement of Vertex's pipeline
Career Progression
Prior to his current roles, Dr. Digiusto held several key positions in the field of stem cell and regenerative medicine:
- Chief Technical Officer, Semma Therapeutics
- Played a pivotal role in the development of Semma's pipeline of cell-based therapies for diabetes and other metabolic disorders
- Oversaw the scale-up and optimization of manufacturing processes to support clinical trials
- Executive Director - Stem Cell and Cellular Therapeutics Operations, Stanford Health Care
- Established and led Stanford's stem cell and cellular therapeutics program, driving advancements in clinical research and patient care
- Research Professor - Virology, City of Hope
- Conducted groundbreaking research in the areas of viral vectors and gene delivery systems for cell-based therapies
Academic Background
Dr. Digiusto holds a Ph.D. in Molecular Biology from the University of California, San Diego, where he specialized in stem cell biology and regenerative medicine. His academic achievements include numerous peer-reviewed publications and prestigious research grants.
Areas of Expertise
- Stem cell research and engineering
- Cell and gene therapy development
- Regenerative medicine and tissue engineering
- Cellular manufacturing and process optimization
- Regulatory affairs and quality assurance
- Cross-functional team leadership and collaboration
Professional Impact
Throughout his career, Dr. Digiusto has made significant contributions to the advancement of cellular therapeutics. He has led the development of several innovative cell-based therapies that have advanced to clinical trials, and his work has contributed to the successful commercialization of cutting-edge regenerative medicine products.
Conclusion
With his extensive experience, technical expertise, and strategic vision, Dr. David Digiusto is a highly sought-after leader in the field of stem cell research and regenerative medicine. His proven track record of driving innovation and delivering tangible results makes him a valuable asset to the companies he serves.
